S&P 500

5.652,24

0,37%

Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.

Registrieren

Startseite
Investieren
Aktien
USA
USOTC
Hepion Pharmaceuticals Inc (PK) (CTRVP)
Hepion Pharmaceuticals Inc (PK) (CTRVP) News

CTRVP

Hepion Pharmaceuticals (PK) (CTRVP)

Hepion Pharmaceuticals Inc (PK)

Von:

Regulatory News

Text Search:

Sortieren nach:

Non-Regulatory News

Showing the most relevant articles for your search:USOTC:CTRVP

1 2 3 4 5 Next >>

Datum	Zeit	Quelle	Überschrift	Symbol	Firma
15/07/2024	23h17	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	USOTC:CTRVP	Hepion Pharmaceuticals Inc (PK)
11/07/2024	15h46	Edgar (US Regulatory)	Form S-1 - General form for registration of securities under the Securities Act of 1933	USOTC:CTRVP	Hepion Pharmaceuticals Inc (PK)
07/03/2024	22h15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	USOTC:CTRVP	Hepion Pharmaceuticals Inc (PK)
06/03/2024	22h30	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	USOTC:CTRVP	Hepion Pharmaceuticals Inc (PK)
22/02/2024	02h01	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	USOTC:CTRVP	Hepion Pharmaceuticals Inc (PK)
22/02/2024	02h01	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	USOTC:CTRVP	Hepion Pharmaceuticals Inc (PK)
20/02/2024	22h15	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:CTRVP	Hepion Pharmaceuticals Inc (PK)
07/02/2024	22h15	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:CTRVP	Hepion Pharmaceuticals Inc (PK)
07/12/2023	14h41	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:CTRVP	Hepion Pharmaceuticals Inc (PK)
28/11/2023	12h55	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	USOTC:CTRVP	Hepion Pharmaceuticals Inc (PK)
20/11/2023	21h59	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	USOTC:CTRVP	Hepion Pharmaceuticals Inc (PK)
31/10/2023	21h15	Edgar (US Regulatory)	Form S-1 - General form for registration of securities under the Securities Act of 1933	USOTC:CTRVP	Hepion Pharmaceuticals Inc (PK)
03/10/2023	23h22	Edgar (US Regulatory)	Form D - Notice of Exempt Offering of Securities	USOTC:CTRVP	Hepion Pharmaceuticals Inc (PK)
02/10/2023	22h52	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	USOTC:CTRVP	Hepion Pharmaceuticals Inc (PK)
20/09/2023	17h27	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	USOTC:CTRVP	Hepion Pharmaceuticals Inc (PK)
19/09/2023	15h01	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	USOTC:CTRVP	Hepion Pharmaceuticals Inc (PK)
14/08/2023	22h12	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	USOTC:CTRVP	Hepion Pharmaceuticals Inc (PK)
14/07/2023	23h12	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	USOTC:CTRVP	Hepion Pharmaceuticals Inc (PK)
12/05/2023	22h19	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:CTRVP	Hepion Pharmaceuticals Inc (PK)
10/04/2023	22h52	Edgar (US Regulatory)	Annual Report (10-k)	USOTC:CTRVP	Hepion Pharmaceuticals Inc (PK)
03/04/2023	12h02	Edgar (US Regulatory)	Notification That Annual Report Will Be Submitted Late (nt 10-k)	USOTC:CTRVP	Hepion Pharmaceuticals Inc (PK)
21/11/2022	23h08	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	USOTC:CTRVP	Hepion Pharmaceuticals Inc (PK)
14/11/2022	22h38	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:CTRVP	Hepion Pharmaceuticals Inc (PK)
09/11/2022	23h21	Edgar (US Regulatory)	Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)	USOTC:CTRVP	Hepion Pharmaceuticals Inc (PK)
09/11/2022	12h07	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:CTRVP	Hepion Pharmaceuticals Inc (PK)
17/10/2022	23h14	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:CTRVP	Hepion Pharmaceuticals Inc (PK)
05/08/2022	22h07	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:CTRVP	Hepion Pharmaceuticals Inc (PK)
26/07/2022	22h06	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	USOTC:CTRVP	Hepion Pharmaceuticals Inc (PK)
25/07/2022	13h13	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	USOTC:CTRVP	Hepion Pharmaceuticals Inc (PK)
05/07/2022	14h34	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	USOTC:CTRVP	Hepion Pharmaceuticals Inc (PK)